Cortistatin as a therapeutic target in inflammation

Alicia Rubio, Jesús Ávila, Luis de Lecea

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Cortistatin (CST) is a recently discovered neuropeptide from the somatostatin gene family, named after its predominantly cortical expression and ability to depress cortical activity. CST shows many remarkable structural and functional similarities to its related neuropeptide somatostatin, or somatotropin release-inhibiting factor. However, the many physiological differences between CST and somatostatin are just as remarkable as the similarities. CST-29 has recently been shown to prevent inflammation in rodent models for human diseases, raising novel therapeutic properties to this neuropeptide. In this review, the authors address a new possible role for CST in the immune system and evaluate the possible therapeutic use of CST to treat disorders associated with inflammation.

Original languageEnglish
Pages (from-to)1-9
Number of pages9
JournalExpert Opinion on Therapeutic Targets
Volume11
Issue number1
DOIs
Publication statusPublished - Jan 2007

Fingerprint

Inflammation
Somatostatin
Neuropeptides
Therapeutics
Immune system
Therapeutic Uses
cortistatin
Immune System
Rodentia
Genes

Keywords

  • Crohn's disease
  • Immune system
  • Intestinal inflammation
  • Somatostatin

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Molecular Medicine

Cite this

Cortistatin as a therapeutic target in inflammation. / Rubio, Alicia; Ávila, Jesús; de Lecea, Luis.

In: Expert Opinion on Therapeutic Targets, Vol. 11, No. 1, 01.2007, p. 1-9.

Research output: Contribution to journalArticle

Rubio, Alicia ; Ávila, Jesús ; de Lecea, Luis. / Cortistatin as a therapeutic target in inflammation. In: Expert Opinion on Therapeutic Targets. 2007 ; Vol. 11, No. 1. pp. 1-9.
@article{3cd1a61101f4491e8ad2c8f2acb9dcff,
title = "Cortistatin as a therapeutic target in inflammation",
abstract = "Cortistatin (CST) is a recently discovered neuropeptide from the somatostatin gene family, named after its predominantly cortical expression and ability to depress cortical activity. CST shows many remarkable structural and functional similarities to its related neuropeptide somatostatin, or somatotropin release-inhibiting factor. However, the many physiological differences between CST and somatostatin are just as remarkable as the similarities. CST-29 has recently been shown to prevent inflammation in rodent models for human diseases, raising novel therapeutic properties to this neuropeptide. In this review, the authors address a new possible role for CST in the immune system and evaluate the possible therapeutic use of CST to treat disorders associated with inflammation.",
keywords = "Crohn's disease, Immune system, Intestinal inflammation, Somatostatin",
author = "Alicia Rubio and Jes{\'u}s {\'A}vila and {de Lecea}, Luis",
year = "2007",
month = "1",
doi = "10.1517/14728222.11.1.1",
language = "English",
volume = "11",
pages = "1--9",
journal = "Expert Opinion on Therapeutic Targets",
issn = "1472-8222",
publisher = "Informa Healthcare",
number = "1",

}

TY - JOUR

T1 - Cortistatin as a therapeutic target in inflammation

AU - Rubio, Alicia

AU - Ávila, Jesús

AU - de Lecea, Luis

PY - 2007/1

Y1 - 2007/1

N2 - Cortistatin (CST) is a recently discovered neuropeptide from the somatostatin gene family, named after its predominantly cortical expression and ability to depress cortical activity. CST shows many remarkable structural and functional similarities to its related neuropeptide somatostatin, or somatotropin release-inhibiting factor. However, the many physiological differences between CST and somatostatin are just as remarkable as the similarities. CST-29 has recently been shown to prevent inflammation in rodent models for human diseases, raising novel therapeutic properties to this neuropeptide. In this review, the authors address a new possible role for CST in the immune system and evaluate the possible therapeutic use of CST to treat disorders associated with inflammation.

AB - Cortistatin (CST) is a recently discovered neuropeptide from the somatostatin gene family, named after its predominantly cortical expression and ability to depress cortical activity. CST shows many remarkable structural and functional similarities to its related neuropeptide somatostatin, or somatotropin release-inhibiting factor. However, the many physiological differences between CST and somatostatin are just as remarkable as the similarities. CST-29 has recently been shown to prevent inflammation in rodent models for human diseases, raising novel therapeutic properties to this neuropeptide. In this review, the authors address a new possible role for CST in the immune system and evaluate the possible therapeutic use of CST to treat disorders associated with inflammation.

KW - Crohn's disease

KW - Immune system

KW - Intestinal inflammation

KW - Somatostatin

UR - http://www.scopus.com/inward/record.url?scp=33846221826&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846221826&partnerID=8YFLogxK

U2 - 10.1517/14728222.11.1.1

DO - 10.1517/14728222.11.1.1

M3 - Article

C2 - 17150030

AN - SCOPUS:33846221826

VL - 11

SP - 1

EP - 9

JO - Expert Opinion on Therapeutic Targets

JF - Expert Opinion on Therapeutic Targets

SN - 1472-8222

IS - 1

ER -